Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata mainly affects young people, often showing as patchy hair loss on the scalp.

People with alopecia areata often have lower vitamin D levels than healthy people.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Lower BDNF levels link to worse depression in alopecia areata patients.

People with alopecia areata had lower vitamin D levels, but these levels didn't relate to many aspects of the condition.

Methotrexate with corticosteroids can help regrow hair in severe alopecia areata but may cause relapses and side effects.

Vitamin D may help with certain types of hair loss in women.

Low vitamin D levels may worsen or cause alopecia areata.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.

Baricitinib is effective and safe for treating severe alopecia areata.

Herbal products are preferred for treating hair loss due to their reliability in promoting regrowth.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

308 nm excimer light therapy may help hair regrowth in alopecia areata with delayed results and no serious side effects.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Certain scalp patterns can indicate the severity and activity of hair loss in Turkish alopecia patients.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Hair loss is often linked to thyroid problems, especially in women and older people, and screening for thyroid issues is advised for those with hair loss.

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.